Latest Manufacturing Capacity News

Page 1 of 22
IDT Australia expects FY27 revenue of $19 million to $20 million and EBITDA of $1 million to $1.5 million, marking a projected swing from a $0.92 million FY26 loss. The forecast rests on larger customer contracts, a five-year radiopharmaceutical deal and roughly $7 million of manufacturing upgrades.
Victor Sage
Victor Sage
18 Nov 2026
Anteris Technologies reported a wider third-quarter loss as spending accelerated on its PARADIGM heart-valve trial and manufacturing expansion. The company ended September with US$236.3 million in cash, but also retained unresolved weaknesses in financial reporting controls.
Ada Torres
Ada Torres
11 Nov 2026
Ball’s operating performance strengthened in the third quarter, with comparable EPS, operating earnings and global shipments all higher year on year. But a US$475 million noncash pension settlement charge pushed the aluminum packaging group to a US$94 million GAAP loss and cash generation remains thin.
Maxwell Dee
Maxwell Dee
4 Nov 2026
Lennox is replacing the head of its Building Climate Solutions segment with an internal executive while retaining the outgoing leader as a strategic adviser through February 2028. The transition preserves customer and leadership continuity, but the filing does not indicate any change to financial guidance.
Maxwell Dee
Maxwell Dee
3 Nov 2026
Orthocell has recorded its strongest month of US Remplir sales since launch, with 92 units generating A$279,000 in October. The result points to improving surgeon adoption and hospital access, although one month of sales does not yet establish a durable run rate or profitability.
Victor Sage
Victor Sage
2 Nov 2026
KTEK Aerosystems has restarted deliveries under its main production program and is targeting 150 complete airframe sets per month. But the recovery is entering its most demanding phase, with A$2.31 million of quarterly operating cash outflow and only 1.1 quarters of funding under the ASX measure.
Victor Sage
Victor Sage
30 Oct 2026
Korvest expects its first-half FY27 trading result to come in significantly above the prior corresponding period and ahead of the stronger second half of FY26. The outlook follows record FY26 revenue, a growing order book and major investment in manufacturing capacity.
Victor Sage
Victor Sage
30 Oct 2026
Optiscan has moved its InForm and InVue medical-imaging devices into formal US FDA review after a quarter of intensive regulatory and clinical work. The milestone comes with $11.093 million in cash and a reported 3.5 quarters of funding at the latest operating burn rate.
Victor Sage
Victor Sage
30 Oct 2026
DXN has delivered a sharp revenue rebound and lifted its backlog to A$30.8 million, but the growth story is complicated by the expected cancellation of its maiden A$8.8 million AI contract. The company is relying on a new A$12.2 million project, expanding factories and improved customer collections to convert momentum into cash.
Victor Sage
Victor Sage
30 Oct 2026
Innovaero Technologies has reported a $5.917 million FY2026 loss as it prepares to scale OWL drone production after its ASX debut and $40 million capital raise. The annual report shows a better-funded business, but one still reliant on government contracts, certification and forecast production work.
Victor Sage
Victor Sage
28 Oct 2026
Electrovaya will invest approximately A$2.0 million in Janus Electric through a proposed placement, while Janus has placed initial battery orders worth about A$37.5 million for its North American truck programme. The investment remains subject to completion conditions, and the battery orders depend on agreed delivery schedules.
Maxwell Dee
Maxwell Dee
28 Oct 2026
Vitrafy has expanded its US blood and cell therapy partnerships while preparing Guardion for a planned medical device listing by the end of 2026. The company ended September with A$38.3 million in cash and term deposits, but expects spending to rise as validation and manufacturing accelerate.
Victor Sage
Victor Sage
28 Oct 2026

Browse the archive

Full archive